Shyam M. Investor
Shyam M. is a Principal at Medicxi with a background in biochemistry, medicine, and drug development. With experience as an Associate at Medicxi and as a Scientific Founder at Cleavr Ltd, he has a proven track record in developing novel biotherapeutics. As a Director at ShyDen Biotechnology, he co-founded a company focused on antibody-based therapies. Shyam is a highly skilled independent consultant, specializing in Immuno-Oncology cell therapy. He holds a Distinction in MRes. Translational Medicine from Imperial College London and a First Class Honours degree in Biochemistry. Shyam is actively involved in cancer conferences and business incubation professionals groups. Connect with him on LinkedIn at https://www.linkedin.com/in/smasrani.
Headquarters:
United Kingdom
